Ronald L. Corbett
Bristol-Myers Squibb (Germany)(DE)Bristol-Myers Squibb (United States)(US)
Publications by Year
Research Areas
Asymmetric Synthesis and Catalysis, Cytokine Signaling Pathways and Interactions, Synthesis of heterocyclic compounds, Synthesis and Reactivity of Sulfur-Containing Compounds, Synthesis and biological activity
Most-Cited Works
- → Design, Synthesis, and Structure−Activity Relationships of Macrocyclic Hydroxamic Acids That Inhibit Tumor Necrosis Factor α Release in Vitro and in Vivo(2001)79 cited
- → Discovery of Macrocyclic Hydroxamic Acids Containing Biphenylmethyl Derivatives at P1‘, a Series of Selective TNF-α Converting Enzyme Inhibitors with Potent Cellular Activity in the Inhibition of TNF-α Release(2001)44 cited
- → Rational design, synthesis and structure–activity relationships of a cyclic succinate series of TNF-α converting enzyme inhibitors. Part 2: lead optimization(2003)30 cited
- → Synthesis and structure–activity relationship of a novel sulfone series of TNF-α converting enzyme inhibitors(2004)29 cited
- → Asymmetric Synthesis of 2,3-Disubstituted Succinates via Chiral Oxazolidinone Controlled Displacement of .alpha.-Trifluoromethanesulfonate Substituted Esters(1995)27 cited
- → Benzyl and t-butyl sulfoxides as sulfenyl halide equivalents: a convenient preparation of benzisothiazolones(1992)27 cited
- → Rational design, synthesis and structure–Activity relationships of a cyclic succinate series of TNF-α converting enzyme inhibitors. Part 1: lead identification(2003)26 cited
- → Asymmetric Synthesis of trans-2,3-Piperidinedicarboxylic Acid and trans-3,4-Piperidinedicarboxylic Acid Derivatives(2002)24 cited
- → Novel 1-(pyridylphenyl)-1-phenyl-2-imidazolylethanols with topical antiinflammatory activity(1992)22 cited
- → Heteroaryl-Fused 2-Phenylisothiazolone Inhibitors of Cartilage Breakdown(1994)17 cited